商业与投资论坛
854
商业与投资论坛Business and Investment Forum:
Translational Medicine: Perspectives from Entrepreneur and Investors
|
时间Time |
活动内容 Content |
地点 Address |
|
13:00-14:00 |
报告（三位主讲） Presentations |
邵逸夫科技馆一楼演讲厅117 Room 117,Sir Run Run Shaw Science and Meeting Hall |
|
14:00-14:20 |
茶歇 Coffee and Tea Break |
|
|
14:20-16:00 |
沙龙 Panel Discussion |
|
June 26 Afternoon |
||
|
Chairpersons: Peter Luo, Ph.D., Co-founder & Former CTO, AbMaxis, a wholly owned subsidiary of Merck; Former Director, Biologics, Merck & Co. S. Benjamin Hua, Ph.D., Adjunct Professor, ZCNI, President and CEO, Avalon BioSciences |
||
|
13:00-13:20 |
Peter Luo, Ph.D., Co-founder & Former CTO, AbMaxis, a wholly owned subsidiary of Merck; Former Director, Biologics, Merck & Co. |
Bridging the innovative technology with novel product development: a personal journey from biotech (Abmaxis) to big pharma (Merck) |
|
13:20-13:40 |
Frank Zhang, Ph.D., CEO, GenScript |
A successful biology CRO business model: GenScript story |
|
13:40-14:00 |
Wen Chen, MBA, Vice-President, TigerMed 泰格医药 |
The rise of Tigermed: A combination of timing, market demand and its people |
|
14:00-14:20 |
Coffee and Tea Break |
|
|
14:20-16:00 |
参加沙龙的嘉宾: Leon Chen, Ph.D., Partner, Fidelity Asia Ventures 富达风险投资 合伙人 James Li, M.D., Partner, KPCB China Fund, 凯鹏华盈创投基金 合伙人 Walter Lau, Ph.D., Managing Partner, Shanghai Cenova Ventures 千骥创投 Stella Xu, Ph.D., Executive Direcotr, Roche Global Pharma Partnering Frank Zhang, Ph.D., CEO, GenScript Wen Chen, MBA, Executive Vice-President, TigerMed 泰格医药 Peter Luo, Ph.D., Co-founder & Former CTO, AbMaxis, a wholly owned subsidiary of Merck; Former Director, Biologics, Merck & Co. |
|
